A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain for adults.

The FDA has approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid ...

Family suing Malibu rehab facility. NBC News, The New York Times, National Public Radio and Politico must vacate their Pentagon office spaces in two weeks for other media organizations — including at ...

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

It was given to people who had acute surgical pain from either abdominoplasty, also known as a tummy tuck, or bunion surgery.

Damage to myelin, the protective sheath surrounding nerve fibers, impairs the brain's ability to transmit signals efficiently. This condition, known as demyelination, disrupts motor function, sensory ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

The endTB trial is one of four recent randomized controlled trials testing new, shorter, and less toxic treatment regimens ...